Unknown PHASE4 INTERVENTIONAL NCT01335334

H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

Helicobacter Pylori Eradication Using a Bismuth Quadruple Therapy Among Asymptomatically Infected Adults in El Paso, Texas: A Pilot Study.

Sponsor: The University of Texas Health Science Center, Houston

Conditions H. Pylori Infection

Interventions bismuth subcitrate potassium, metronidazole,tetracycline hydrochloride and omeprazole

Updated 6 times since 2017 Last updated: Apr 13, 2011 Started: Mar 31, 2011 Primary completion: Jun 30, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on H. Pylori Infection, this trial is ongoing. The trial is conducted by The University of Texas Health Science Center, Houston and has accumulated 6 data snapshots since 2011. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Texas Health Science Center, Houston

Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• El Paso, United States